Apertura Gene Therapy
Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Lexeo Therapeutics, Inc. (LXEO) announced a series of strategic transactions to expand its presence in Friedreich ataxia (FA), including a definitive agreement to acquire privately held clinical-stage company Ajax Therapeutics, Inc. The acquisition adds multiple…
Impact: Apertura Gene Therapy signed an option agreement with Lexeo to license a novel blood-brain barrier-crossing capsid enabling a less invasive route of CNS administration.
Sep 22, 2026 · 6 articles
55
Lexeo Therapeutics signed option agreement Apertura Gene TherapyLexeo Acquires Mantle...
ERGEN INTELLIGENCE
Track Apertura Gene Therapy live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard